Atlas FDA

t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM System

FDA premarket approval P140015/S029 · decided 2019-12-19

Approval details

PMA number
P140015
Supplement
S029
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM System
Generic name
Pump, infusion, insulin, to be used with invasive glucose sensor
Applicant
Tandem Diabetes Care, Inc.
Date received
2019-11-20
Decision date
2019-12-19
Days to decision
29 days
Decision code
OK30
Product code
OYC
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Rework process change related to the assembling of the Printed Circuit Board Assembly (PCBA) at a Tandem supplier. The PCBA is a component of the Tandem t:slim X2 Insulin Pump system.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Control-IQ+ technology (K260429)Tandem Diabetes Care, Inc.2026-04-24
Tandem Mobi insulin pump with interoperable technology (K253074)Tandem Diabetes Care, Inc.2025-11-06
t:slim X2 insulin pump with interoperable technology (K250792)Tandem Diabetes Care, Inc.2025-09-24
Control-IQ+ technology (K250798)Tandem Diabetes Care, Inc.2025-05-21
Control-IQ+ technology (K243823)Tandem Diabetes Care, Inc.2025-02-24
Tandem Mobi Insulin Pump with interoperable technology (K241078)Tandem Diabetes Care, Inc.2024-07-26
Tandem Mobi insulin pump with interoperable technology (K240309)Tandem Diabetes Care, Inc.2024-03-21
t:slim X2 Insulin Pump with Interoperable Technology (K232380)Tandem Diabetes Care, Inc.2023-11-03